Centre for Preclinical
Drug Development
The Centre for Preclinical Drug Development (CPDD) was established to bridge the gap between academic discovery and clinical readiness, enabling investigators to advance from target validation and early-stage assays to in vivo preclinical development.
Why work with CPDD?
End-to-end translational expertise to advance scientific discoveries from concept to impact
The best of both worlds: academic innovation paired with responsive, CRO-style project support
Flexible engagement models tailored to your unique needs and goals
Strategic scientific guidance backed by experienced project planning and execution support
Enhanced industry and academic positioning through high-value collaborations and partnerships
Strong collaborative network spanning academia, biotechnology, and industry
Fee-for-service solutions designed to provide measurable results
Structured project delivery process, including consultation, assessment, study design, execution, and comprehensive reporting
Project Inquiry
Partner with CPDD through a collaborative, end-to-end process that moves from confidential consultation and expert project assessment to tailored study design, integrated preclinical research, and strategic decision-making support.
